ALPHARETTA, GA, UNITED STATES, January 7, 2025 /EINPresswire.com/ -- PlexusDx, a leader in AI-powered precision health, and Evexia Diagnostics, renowned for their comprehensive clinical laboratory services, are excited to announce a groundbreaking partnership. This collaboration will expand access to advanced at-home genetic testing, focusing on Pharmacogenomics (PGx) and Nutrigenomics (NGx) to enhance personalized healthcare for both consumers and healthcare providers.

PlexusDx’s mission to deliver science-based recommendations through cutting-edge AI and genetic analysis aligns seamlessly with Evexia Diagnostics’ commitment to providing fast, reliable diagnostic solutions tailored to the needs of functional and integrative medicine practitioners. Together, the two companies aim to revolutionize how individuals approach their health by empowering them with actionable insights derived from their unique genetic profiles.

Pharmacogenomics and Nutrigenomics: Precision Health for AllPharmacogenomics (PGx) testing from PlexusDx identifies which medications are most compatible with an individual’s genetic makeup, ensuring more effective treatment while minimizing adverse side effects. As over 66% of U.S. adults take at least one prescription medication, this innovative approach can significantly improve treatment outcomes.

In addition to pharmacogenomics, PlexusDx offers Nutrigenomics (NGx) testing, which evaluates an individual's genetic response to macronutrients, vitamins, minerals, and potential food sensitivities. With over 75% of Americans looking to improve their health through diet and nutrition, this test empowers users to make smarter dietary choices tailored to their genetic needs.

Evexia Diagnostics’ network of over 20,000 clinical practitioners will now have access to these advanced testing services, which not only...